"Meningeal Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Benign and malignant neoplastic processes that arise from or secondarily involve the meningeal coverings of the brain and spinal cord.
Descriptor ID |
D008577
|
MeSH Number(s) |
C04.588.614.250.580 C10.551.240.500
|
Concept/Terms |
Meningeal Neoplasms- Meningeal Neoplasms
- Neoplasms, Meningeal
- Meningeal Neoplasm
- Neoplasm, Meningeal
- Meningeal Tumors
- Meningeal Tumor
- Tumor, Meningeal
- Tumors, Meningeal
Malignant Meningeal Neoplasms- Malignant Meningeal Neoplasms
- Malignant Meningeal Neoplasm
- Meningeal Neoplasm, Malignant
- Neoplasm, Malignant Meningeal
- Neoplasms, Malignant Meningeal
- Meningeal Neoplasms, Malignant
- Meningeal Cancer
- Cancer, Meningeal
- Cancers, Meningeal
- Meningeal Cancers
Intracranial Meningeal Neoplasms- Intracranial Meningeal Neoplasms
- Intracranial Meningeal Neoplasm
- Meningeal Neoplasm, Intracranial
- Neoplasm, Intracranial Meningeal
- Neoplasms, Intracranial Meningeal
- Meningeal Neoplasms, Intracranial
Leptomeningeal Neoplasms- Leptomeningeal Neoplasms
- Leptomeningeal Neoplasm
- Neoplasm, Leptomeningeal
- Neoplasms, Leptomeningeal
Spinal Meningeal Neoplasms- Spinal Meningeal Neoplasms
- Meningeal Neoplasm, Spinal
- Meningeal Neoplasms, Spinal
- Neoplasm, Spinal Meningeal
- Neoplasms, Spinal Meningeal
- Spinal Meningeal Neoplasm
Benign Meningeal Neoplasms- Benign Meningeal Neoplasms
- Benign Meningeal Neoplasm
- Meningeal Neoplasm, Benign
- Neoplasm, Benign Meningeal
- Neoplasms, Benign Meningeal
- Meningeal Neoplasms, Benign
|
Below are MeSH descriptors whose meaning is more general than "Meningeal Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Meningeal Neoplasms".
This graph shows the total number of publications written about "Meningeal Neoplasms" by people in this website by year, and whether "Meningeal Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 4 | 4 | 8 |
1995 | 9 | 0 | 9 |
1996 | 10 | 1 | 11 |
1997 | 6 | 0 | 6 |
1998 | 3 | 0 | 3 |
1999 | 3 | 1 | 4 |
2000 | 5 | 0 | 5 |
2001 | 2 | 1 | 3 |
2002 | 4 | 0 | 4 |
2003 | 12 | 3 | 15 |
2004 | 6 | 3 | 9 |
2005 | 5 | 2 | 7 |
2006 | 6 | 0 | 6 |
2007 | 3 | 0 | 3 |
2008 | 6 | 1 | 7 |
2009 | 5 | 1 | 6 |
2010 | 6 | 2 | 8 |
2011 | 5 | 1 | 6 |
2012 | 5 | 1 | 6 |
2013 | 5 | 0 | 5 |
2014 | 8 | 0 | 8 |
2015 | 10 | 0 | 10 |
2016 | 3 | 1 | 4 |
2017 | 7 | 2 | 9 |
2018 | 8 | 1 | 9 |
2019 | 6 | 0 | 6 |
2020 | 8 | 0 | 8 |
2021 | 9 | 1 | 10 |
2022 | 7 | 0 | 7 |
2023 | 10 | 0 | 10 |
2024 | 5 | 0 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Meningeal Neoplasms" by people in Profiles.
-
Aggressive human MenG C meningiomas have a molecular counterpart in canines. Acta Neuropathol. 2024 Feb 20; 147(1):42.
-
Evaluation of the SSTR2-targeted Radiopharmaceutical 177Lu-DOTATATE and SSTR2-specific 68Ga-DOTATATE PET as Imaging Biomarker in Patients with Intracranial Meningioma. Clin Cancer Res. 2024 02 16; 30(4):680-686.
-
The importance of considering competing risks in recurrence analysis of intracranial meningioma. J Neurooncol. 2024 Feb; 166(3):503-511.
-
Enhancing mitosis quantification and detection in meningiomas with computational digital pathology. Acta Neuropathol Commun. 2024 Jan 11; 12(1):7.
-
Volumetric growth rate of incidentally found meningiomas on immunotherapy. J Neurooncol. 2024 Jan; 166(2):303-307.
-
Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses. Nat Med. 2023 Dec; 29(12):3067-3076.
-
Super-enhancer hijacking drives ectopic expression of hedgehog pathway ligands in meningiomas. Nat Commun. 2023 10 07; 14(1):6279.
-
Integrated clinical genomic analysis reveals xenobiotic metabolic genes are downregulated in meningiomas of current smokers. J Neurooncol. 2023 Jun; 163(2):397-405.
-
Hypermitotic meningiomas harbor DNA methylation subgroups with distinct biological and clinical features. Neuro Oncol. 2023 03 14; 25(3):520-530.
-
Docetaxel targets aggressive methylation profiles and serves as a radiosensitizer in high-risk meningiomas. Neuro Oncol. 2023 03 14; 25(3):508-519.